Published in Bone on January 01, 1990
Whole body bone mineral content in healthy children and adolescents. Arch Dis Child (1997) 2.36
Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest (1994) 2.33
Comparison of quantitative computed tomography-based measures in predicting vertebral compressive strength. Bone (2006) 1.33
Structural basis of growth-related gain and age-related loss of bone strength. Rheumatology (Oxford) (2008) 1.26
Vertebral size in elderly women with osteoporosis. Mechanical implications and relationship to fractures. J Clin Invest (1995) 1.15
Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral density. Osteoporos Int (2004) 1.14
Osteoporosis in men. BMJ (1992) 1.10
Vertebral structure and strength in vivo and in vitro. Calcif Tissue Int (1993) 0.99
Mechanical contributions of the cortical and trabecular compartments contribute to differences in age-related changes in vertebral body strength in men and women assessed by QCT-based finite element analysis. J Bone Miner Res (2011) 0.99
Aging and strength of bone as a structural material. Calcif Tissue Int (1993) 0.92
Gender differences in volumetric bone density: a study of opposite-sex twins. Osteoporos Int (2003) 0.86
Bone health and the female athlete triad in adolescent athletes. Phys Sportsmed (2011) 0.85
Association between levels of serum ferritin and bone mineral density in Korean premenopausal and postmenopausal women: KNHANES 2008-2010. PLoS One (2014) 0.84
Sexual Dimorphism in Newborn Vertebrae and Its Potential Implications. J Pediatr (2015) 0.81
Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax (2005) 0.80
Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis. Clin Rheumatol (1995) 0.80
Background for studies on the treatment of male osteoporosis: state of the art. Ann Rheum Dis (2000) 0.80
Contribution of the vertebral posterior elements in anterior-posterior DXA spine scans in young subjects. J Bone Miner Res (2009) 0.78
Age-related trends in vertebral dimensions. J Anat (2015) 0.78
In vivo 3D reconstruction of human vertebrae with the three-dimensional X-ray absorptiometry (3D-XA) method. Osteoporos Int (2007) 0.78
Morphometry of the lower lumbar intervertebral discs and endplates: comparative analyses of new MRI data with previous findings. Eur Spine J (2016) 0.77
Standardization and validation of a novel and simple method to assess lumbar dural sac size. Clin Radiol (2014) 0.77
Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health. Int J Endocrinol (2017) 0.75
Effects of Leisure-Time Physical Activity on Vertebral Dimensions in the Northern Finland Birth Cohort 1966. Sci Rep (2016) 0.75
Age- and sex-related regional compressive strength characteristics of human lumbar vertebrae in osteoporosis. J Multidiscip Healthc (2008) 0.75
Hip fractures in men. Osteoporos Int (1996) 0.75
Vertebral cross-sectional area: an orphan phenotype with potential implications for female spinal health. Osteoporos Int (2016) 0.75
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology (2001) 3.00
Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res (2001) 2.89
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int (2007) 2.46
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int (2006) 2.33
Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int (2005) 2.23
Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord (1998) 2.07
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia (2005) 1.79
Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int (2008) 1.78
Fracture risk associated with the use of morphine and opiates. J Intern Med (2006) 1.71
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res (1993) 1.57
Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) (1979) 1.49
Stereological considerations concerning the measurement of individual osteoid seams and resorption cavities. Bone Miner (1994) 1.47
Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ (2000) 1.47
Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur J Clin Invest (2002) 1.46
Autosomal dominant osteopetrosis. Clin Orthop Relat Res (1993) 1.44
Familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) (1994) 1.42
Stroke in relation to use of raloxifene and other drugs against osteoporosis. Osteoporos Int (2010) 1.42
Polymorphisms of muscle genes are associated with bone mass and incident osteoporotic fractures in Caucasians. Calcif Tissue Int (2013) 1.40
Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int (1989) 1.39
[Costs of different intervention strategies to prevent hip fractures]. Ugeskr Laeger (1999) 1.39
Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int (2006) 1.39
Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut (2000) 1.33
Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2005) 1.30
Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand J Clin Lab Invest (2006) 1.29
The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab (1988) 1.29
Fracture risk in patients treated for hyperthyroidism. Thyroid (2000) 1.25
Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone (1999) 1.22
Age- and sex-related changes in iliac cortical bone mass and remodeling. Bone (1994) 1.19
Fractures in patients with primary idiopathic hypothyroidism. Thyroid (2000) 1.17
Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone (1987) 1.17
Histomorphometric analysis of normal bone from the iliac crest. Acta Pathol Microbiol Scand A (1978) 1.16
Normal vertebral body size and compressive strength: relations to age and to vertebral and iliac trabecular bone compressive strength. Bone (1986) 1.16
Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcif Tissue Int (2003) 1.14
Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. Metab Bone Dis Relat Res (1984) 1.14
Fracture risk is increased in epilepsy. Acta Neurol Scand (1999) 1.13
Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tissue Res (1978) 1.12
Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int (1999) 1.12
Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone (1996) 1.11
Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach. Bone (1999) 1.10
Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone (1986) 1.10
Effects of 25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort study in healthy Danish women. Eur J Clin Nutr (2012) 1.09
Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int (2011) 1.08
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner (1994) 1.07
A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone (1989) 1.06
Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int (2006) 1.06
Reduced relative risk of fractures among users of lithium. Calcif Tissue Int (2005) 1.05
An evaluation of the quantitative parameters applied in bone histology. Acta Pathol Microbiol Scand A (1978) 1.02
Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res (2003) 1.02
Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity. Gut (1980) 1.01
Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis. Bone (1994) 1.00
Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int (2010) 0.99
Correlation between the compressive strength of iliac and vertebral trabecular bone in normal individuals. Bone (1985) 0.99
Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int (2005) 0.99
Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int (2014) 0.99
Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution. Calcif Tissue Int (1993) 0.98
A model of vertebral trabecular bone architecture and its mechanical properties. Bone (1990) 0.98
The predictive value of quantitative computed tomography for vertebral body compressive strength and ash density. Bone (1989) 0.98
Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2007) 0.98
Reconstruction of the resorptive site in iliac trabecular bone: a kinetic model for bone resorption in 20 normal individuals. Metab Bone Dis Relat Res (1984) 0.97
Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int (1993) 0.97
Estimation of the three-dimensional wall thickness of completed remodeling sites in iliac trabecular bone. Metab Bone Dis Relat Res (1982) 0.97
Age- and gender-related differences in vertebral bone mass, density, and strength. J Bone Miner Res (1999) 0.97
Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone (1999) 0.96
The positive effects of zinc on skeletal strength in growing rats. Bone (2001) 0.96
Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int (2005) 0.96
Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene. Osteoporos Int (2010) 0.96
Osteon cross-sectional size in the iliac crest: variation in normals and patients with osteoporosis, hyperparathyroidism, acromegaly, hypothyroidism and treated epilepsia. Acta Pathol Microbiol Immunol Scand A (1982) 0.96
A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism. Acta Med Scand (1978) 0.96
Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. J Clin Invest (1985) 0.96
Biochemical evidence of disturbed bone metabolism and calcium homeostasis in two types of autosomal dominant osteopetrosis. Acta Med Scand (1988) 0.96
Predicting human vertebral bone strength by vertebral static histomorphometry. Bone (2002) 0.95
Osteopenia with normal vitamin D metabolites after small-bowel resection for Crohn's disease. Scand J Gastroenterol (1984) 0.95
Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol (Copenh) (1977) 0.95
Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. J Endocrinol (1999) 0.94
Maternal and infant vitamin D status during the first 9 months of infant life-a cohort study. Eur J Clin Nutr (2013) 0.94
Morphometric and dynamic studies of bone changes in hypothyroidism. Acta Pathol Microbiol Scand A (1978) 0.94
Trabecular bone remodeling and bone balance in hyperthyroidism. Bone (1985) 0.94
Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods. Bone (1992) 0.93
Fracture risk associated with smoking: a meta-analysis. J Intern Med (2003) 0.93
Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. I: Chemical quantities in serum and urine. Acta Endocrinol (Copenh) (1978) 0.93
Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study. Osteoporos Int (2011) 0.93
Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study. Calcif Tissue Int (2006) 0.93
Effects of exercise and disuse on bone remodeling, bone mass, and biomechanical competence in spontaneously diabetic female rats. Bone (2000) 0.93
Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark. J Intern Med (2003) 0.93
Relationships between static histomorphometry and bone strength measurements in human iliac crest bone biopsies. Bone (1998) 0.93
Anticonvulsant osteomalacia determined by quantitative analysis of bone changes. Population study and possible risk factors. Acta Med Scand (1976) 0.92
Fracture risk in patients treated with loop diuretics. J Intern Med (2006) 0.92
The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects. Bone Miner (1988) 0.92
Biologically meaningful determinants of the in vitro strength of lumbar vertebrae. Bone (1991) 0.92